At Panacea, we are committed to advancing the field of radiation oncology by combining precision and innovation in our breakthrough solutions, empowering clinicians worldwide to treat cancer effectively.
We foster meaningful engagement with medical professionals to exchange clinical insights, cutting-edge tools, scientific research, and expert opinions—all with the goal of defeating cancer through radiation therapy.
By maximizing the clinical potential of our products, research initiatives, and collaborative partnerships with clinical investigators, we drive continuous improvement in patient outcomes.
#DefeatingCancerTogether—through strong relationships with clinicians and researchers, we pioneer breakthroughs in healthcare and shape the future of cancer treatment.
Comprehensive treatment planning tools, 3D conformal dose calculation, and kV image verification.
Advanced 3D-CRT and IMRT treatment planning algorithms with integrated DICOM RT connectivity.
High-resolution cone-beam CT (CBCT) and planar imaging for precise patient positioning prior to fraction delivery.
Independent 3D dose verification and phantom QA protocols designed for medical physicists.
Explore peer-reviewed publications, workflow videos, case studies, and clinical bibliographies.
Step-by-step video demonstrations of clinical workflows on Siddharth II and Bhabhatron 3i systems.
Real-world treatment cases showcasing head & neck, cervical, and prostate radiotherapy fraction delivery.
Published scientific articles, Siddharth II beam characterization papers, and clinical bibliographies.
Partnering with leading cancer institutes to advance radiation therapy technologies.
Advancing Radiobiology, Beam Dosimetry, and Indigenous Linac Technology
Panacea Medical Technologies actively collaborates with Christian Medical College (CMC) Vellore and Tata Memorial Centre on multi-centric clinical trials, clinical evaluation of indigenous linear accelerators, and quality assurance protocols.
